Tweet
Dynamic Advisor Solutions LLC purchased a new position in shares of Express Scripts Holding Co (NASDAQ:ESRX) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 2,706 shares of the company's stock, valued at approximately $208,000.
Several other large investors also recently bought and sold shares of ESRX. Farallon Capital Management LLC acquired a new position in shares of Express Scripts during the 1st quarter worth approximately $71,843,000. State of New Jersey Common Pension Fund D boosted its stake in shares of Express Scripts by 1,500.0% during the 1st quarter. State of New Jersey Common Pension Fund D now owns 800,000 shares of the company's stock worth $55,264,000 after acquiring an additional 750,000 shares during the period. Bank of Montreal Can bought a new position in shares of Express Scripts during the 2nd quarter worth approximately $54,695,000. Smith Asset Management Group LP bought a new position in shares of Express Scripts during the 1st quarter worth approximately $39,686,000. Finally, O Shaughnessy Asset Management LLC boosted its stake in shares of Express Scripts by 65.7% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 1,430,886 shares of the company's stock worth $98,847,000 after acquiring an additional 567,431 shares during the period. 84.52% of the stock is currently owned by hedge funds and other institutional investors. Get Express Scripts alerts:
Several brokerages have recently commented on ESRX. William Blair upgraded Express Scripts from a "market perform" rating to an "outperform" rating in a research note on Wednesday, August 1st. BidaskClub upgraded Express Scripts from a "sell" rating to a "hold" rating in a research note on Tuesday, July 31st. Zacks Investment Research downgraded Express Scripts from a "hold" rating to a "sell" rating in a research note on Monday, July 23rd. Finally, Robert W. Baird downgraded Express Scripts from an "outperform" rating to a "neutral" rating and set a $81.00 target price for the company. in a research note on Friday, July 20th. Three research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating to the stock. Express Scripts presently has an average rating of "Hold" and a consensus target price of $83.58. In related news, insider Christine Houston sold 12,898 shares of the business's stock in a transaction on Friday, August 10th. The stock was sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the sale, the insider now directly owns 110,908 shares in the company, valued at approximately $9,427,180. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website . Insiders own 0.79% of the company's stock.
ESRX opened at $87.34 on Friday. The firm has a market capitalization of $47.02 billion, a P/E ratio of 12.30, a PEG ratio of 1.05 and a beta of 0.95. Express Scripts Holding Co has a 1 year low of $55.80 and a 1 year high of $87.69. The company has a quick ratio of 0.59, a current ratio of 0.71 and a debt-to-equity ratio of 0.69.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Wednesday, August 1st. The company reported $2.22 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $2.20 by $0.02. The business had revenue of $25.64 billion during the quarter, compared to the consensus estimate of $25.43 billion. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The firm's quarterly revenue was up 1.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.73 EPS. research analysts expect that Express Scripts Holding Co will post 9.07 EPS for the current fiscal year.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services